ALLO Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. (ALLO) Institutional Ownership
What the institutions did with ALLO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| BlackRock, Inc. | 30.1M | 9.6% |
| Frazier Life Sciences Management, L.P. | 22.4M | 7.2% |
| Pfizer Inc | 22.0M | 7.0% |
| STATE STREET CORP | 19.0M | 6.1% |
| TPG GP A, LLC | 18.7M | 6.0% |
| Sio Capital Management, LLC | 13.3M | 4.3% |
| PRIMECAP MANAGEMENT CO/CA/ | 13.1M | 4.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.2M | 3.9% |
| FMR LLC | 12.0M | 3.8% |
| CITADEL ADVISORS LLC | 10.1M | 3.2% |
| TWO SIGMA INVESTMENTS, LP | 7.8M | 2.5% |
| GEODE CAPITAL MANAGEMENT, LLC | 7.0M | 2.3% |
| GOLDMAN SACHS GROUP INC | 6.1M | 2.0% |
| GordonMD Global Investments LP | 5.3M | 1.7% |
| MARSHALL WACE, LLP | 5.1M | 1.6% |
| Patient Square Capital LP | 5.1M | 1.6% |
| Aberdeen Group plc | 5.0M | 1.6% |
| MILLENNIUM MANAGEMENT LLC | 4.8M | 1.5% |
| D. E. Shaw & Co., Inc. | 4.7M | 1.5% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.6M | 1.5% |
| MORGAN STANLEY | 4.5M | 1.4% |
| Woodline Partners LP | 4.5M | 1.4% |
| Candriam S.C.A. | 4.3M | 1.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.2M | 1.3% |
| RENAISSANCE TECHNOLOGIES LLC | 3.8M | 1.2% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | Increased | 3.8M | 22.4M | +18.7M |
| Sio Capital Management, LLC | New | 0 | 13.3M | +13.3M |
| BlackRock, Inc. | Increased | 19.1M | 30.1M | +11.1M |
| FMR LLC | Increased | 1.6M | 12.0M | +10.4M |
| STATE STREET CORP | Increased | 8.7M | 19.0M | +10.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6.9M | 12.2M | +5.2M |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 8.4M | 13.1M | +4.7M |
| GordonMD Global Investments LP | Increased | 1.4M | 5.3M | +3.9M |
| HRT FINANCIAL LP | Increased | 19.6K | 3.6M | +3.6M |
| Aberdeen Group plc | Increased | 1.5M | 5.0M | +3.5M |
| MORGAN STANLEY | Increased | 998.8K | 4.5M | +3.5M |
| GOLDMAN SACHS GROUP INC | Increased | 2.8M | 6.1M | +3.4M |
| CITADEL ADVISORS LLC | Increased | 6.8M | 10.1M | +3.3M |
| Walleye Capital LLC | New | 0 | 3.3M | +3.3M |
| RTW INVESTMENTS, LP | New | 0 | 3.3M | +3.3M |
| Ghisallo Capital Management LLC | New | 0 | 3.0M | +3.0M |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 4.1M | 7.0M | +2.9M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 1.7M | 4.2M | +2.5M |
| TWO SIGMA INVESTMENTS, LP | Increased | 5.4M | 7.8M | +2.4M |
| MPM BIOIMPACT LLC | Sold Out | 2.2M | 0 | -2.2M |
| DIMENSIONAL FUND ADVISORS LP | Increased | 1.2M | 3.2M | +2.0M |
| D. E. Shaw & Co., Inc. | Increased | 2.8M | 4.7M | +1.9M |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 2.1M | 3.8M | +1.7M |
| Nuveen, LLC | Reduced | 2.3M | 624.6K | -1.7M |
| NORTHERN TRUST CORP | Increased | 1.3M | 3.0M | +1.7M |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.